Device Trial Radar · NCT03238274
Sofia 2 Lyme FIA Whole Blood Clinical Study
Last checked: Nov 19, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
597
Actual
Start
Jun 6, 2017
Primary completion
Dec 15, 2017
Study completion Dec 15, 2017
Sponsor
- Lead sponsor
- Quidel CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 3, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 1 year
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate the clinical performance of the Sofia® 2 analyzer and Sofia Lyme FIA test in the CLIA waived test environment in comparison to Comparator Method(s) and/or an FDA cleared predicate test(s) using matched finger-stick, whole blood and serum from symptomatic subjects.
Conditions
- Borrelia; Infection, Burgdorferi (Erythema Chronicum Migrans)
Interventions
Sofia 2 Lyme FIA testingDevice
IVD testing of whole blood or serum/plasma to aid in the detection of anti-B. burgdorferi IgG / IgM antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Detection of anti-B. burgdorferi IgG / IgM antibodyTime frame: 15 minutes
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
NECCR Primacare Research, LLC
Fall River, Massachusetts
Main Road Family Medicine
South Westport, Massachusetts
Essentia Institute of Rural Health
Duluth, Minnesota
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.